The COVID-19 pandemic had a major influence on how pharmaceutical businesses market their products. Social distancing and restrictions on in-person interactions have forced businesses adapt their digital marketing strategies to reach their target audience. They use various digital marketing strategies like SEO, PPC advertising, social media marketing, content marketing, email marketing and influencer marketing to advertise their products and engage with their audience. By leveraging these tactics, pharmaceutical companies can effectively communicate the benefits of their products and build trust with their audience. The data analysis of digital marketing activities during the pandemic has helped pharmaceutical companies measure their campaign effectiveness and to make adjustments to improve their performance. By using data to inform their decisions, companies were able to optimize their digital marketing efforts and improve their overall return on investment. The impact of these digital marketing strategies on consumer awareness is mixed. On one hand, digital marketing has provided consumers with easy access to information about COVID-19 treatments and vaccines, and has helped to raise awareness about these products. On the other hand, there have been concerns about the precision and reliability of the information provided by pharmaceutical companies and about the potential for digital marketing to manipulate consumer behavior. While digital marketing has enabled pharmaceutical companies to disseminate important information about COVID-19 treatments and vaccines, there are concerns about the potential impact of digital marketing on vulnerable populations and on the public's trust in the healthcare system. It is important for pharmaceutical companies to be mindful of these concerns and to use digital marketing channels responsibly. It is important for companies to adhere to regulatory guidelines and to avoid misleading or inaccurate information in order to maintain public trust in the healthcare system.